CD4 and cancer: In addition, anti-TIGIT mAb did not alter the expression of CD25 and CTLA-4 in either Foxp3+ CD4+ cells or Foxp3– CD4+ cells in either PH septic (not shown) or CA septic hosts (Supplemental Figure 5).